menopause hormone

Does Menopause Hormone Therapy Influence Dementia Risk?

TOPLINE: A meta-analysis found no clear evidence on whether menopause hormone therapy (MHT) increased, decreased, or had no effect on the risk for dementia or mild cognitive impairment in postmenopausal women, irrespective of the formulation, duration, or age of initiation. According to the authors, the evidence did not support using MHT for the prevention of dementia following menopause at […]

Does Menopause Hormone Therapy Influence Dementia Risk? Read More »

Menopause hormone therapy does not appear to impact dementia risk

by University College London edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Credit: Unsplash/CC0 Public Domain A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia risk in postmenopausal women, in a new study led by University College London (UCL) researchers. The findings, commissioned by the World

Menopause hormone therapy does not appear to impact dementia risk Read More »

Busting brain myths: The evolving story of menopause hormone therapy and cognitive health

by Zahinoor Ismail, Jasper Crockford, Maryam Ghahremani, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin  Editors’ notes The delivery method of MHT—which is available as pills, patches, gels, creams, sprays or vaginal rings—also matters, as each is processed differently. Credit: Unsplash/CC0 Public Domain In the early 2000s, a major women’s health study—Women’s Health Initiative (WHI)—made headlines. As

Busting brain myths: The evolving story of menopause hormone therapy and cognitive health Read More »

Menopause hormone therapy no longer has the FDA’s most-dire warning: Now what?

by Meg Wingerter edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes Credit: Pixabay/CC0 Public Domain Removing the most dire warning from hormonal therapies to treat menopause is likely the right call, women’s health experts say, but exuberance for the treatments could be getting ahead of the evidence. Since 2003, the U.S. Food and Drug Administration

Menopause hormone therapy no longer has the FDA’s most-dire warning: Now what? Read More »

Scroll to Top